Skip to main content
. 2016 Nov 25;8(3):354–362. doi: 10.1111/jdi.12584

Figure 2.

Figure 2

Comparison of prevalence of diabetic cardiovascular autonomic neuropathy (DCAN) according to β‐cell function parameters. (a) Comparison of DCAN prevalence according to fasting insulin resistance (FINS). DCAN prevalence was 32.33%, 26.01% and 52.17% in the three groups, respectively. Significant differences among the three groups were reported (P < 0.001 and P for a trend <0.001). (b) Comparison of DCAN prevalence according to homeostasis model assessment of insulin resistance (HOMA‐IR). DCAN prevalence was 24.39% and 38.25% in the two groups, respectively. Significant differences between the two groups were reported (P < 0.001). (c) Comparison of DCAN prevalence according to homeostasis model assessment of insulin sensitivity index (HOMA‐ISI). DCAN prevalence was 34.49%, 25.92% and 20.75% in the three groups, respectively. There were significant differences among the three groups (P = 0.005 and P for a trend = 0.001). (d) Comparison of DCAN prevalence according to homeostasis model assessment of β –cell function (HOMA‐β). DCAN prevalence was 31.45% and 26.31% in the two groups, respectively. There were no significant differences between the two groups (P = 0.098).